Inactive Instrument

Other languages VG Life Sciences Inc. Other OTC

Equities

VGLS

US91822T1016

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

VG Life Sciences : Attorney Letter with Respect to Current Information	22-07-11
VG Life Sciences : Attorney Letter with Respect to Current Information	22-06-09
VG Life Sciences : Annual Report	22-03-31
Feelux Co., Ltd completed the acquisition of 23.09% stake in VG Life Sciences Inc. from Alpha Holdings, Inc. and others for KRW 17.3 billion.	18-11-22
Alpha Holdings, Inc. cancelled an additional stake of 12.49% in VG Life Sciences Inc from TJU Asset Management, LLC and Penn Life Science, LLC.	17-10-11
VG Life Sciences Inc. announced that it has received $5.226 million in funding from Alpha Holdings, Inc.	16-10-30
Alpha Holdings, Inc. agreed to acquire an additional stake of 12.49% in VG Life Sciences Inc from TJU Asset Management, LLC and Penn Life Science, LLC for KRW 4.7 billion.	16-10-11
VG Life Sciences Inc. announced that it expects to receive $5.23 million in funding from Alpha Holdings, Inc.	16-09-11
VG Life Sciences Inc. Announces Management Changes, Effective April 1, 2016	16-03-30
VG Life Sciences Inc. Auditor Raises 'Going Concern' Doubt	15-04-14
VG Life Sciences Inc. Auditor Raises 'Going Concern' Doubt	15-02-10
VG Life Sciences Announces Issuance of Patent Covering Treatment of Inflammatory Bowel Disease with Clip-Inducing Agent	15-01-29
VGLS Q4 2014 Shareholder Update Letter	15-01-14
VG Life Sciences Inc. Progress Update Phase I Cancer Study	14-09-04
VG Life Sciences Inc. Reports Clinical Outcomes in Phase I Cancer Study	14-03-14
VG Life Sciences, Inc. Announces Update on Phase I Cancer Study	13-12-13
VG Life Sciences Inc : VG Life Sciences Starts Prior Year Audit to Increase Financial Accountability	13-10-16
VG Life Sciences Inc : VG Life Sciences, Inc. $2,235,000 Private Placement	13-10-03
VG Life Sciences Inc. Closes $2,235,000 from Private Fund	13-10-02
VG Life Sciences Inc. announced that it has received $2.24 million in funding.	13-10-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages VG Life Sciences Inc. Other OTC

Equities

VGLS

US91822T1016

Other languages

Filters